Home › NDC Lookup › RxCUI directory › RxCUI 863636

24 HR oxybutynin chloride 5 MG Extended Release Oral Tablet — RxCUI 863636

RxNorm drug concept · Semantic clinical drug
RxCUI 863636 Semantic clinical drug · SCD ● Current RxNorm concept 48 FDA products 118 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI863636
Official name24 HR oxybutynin chloride 5 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asoxyBUTYnin chloride 5 MG 24HR Extended Release Oral Tablet
FDA products mapped48
Package NDCs mapped118
Reported Medicaid activity (SDUD)596,166 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oxybutynin Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The patch works by calming the bladder muscle so it doesn't squeeze unexpectedly. That helps reduce the sudden urge to rush to the bathroom, how often you need to go, and accidenta...
  • What exactly does this patch do — and how long before I notice a difference?
  • You can wear the patch on your abdomen, hip, or buttocks — whichever is most comfortable and easiest to keep covered by clothing. Apply it to clean, dry skin with no lotions, oils,...
  • Where do I put the patch, and how often do I change it?
📖 Read our full Oxybutynin Transdermal Patch guide →

🕸️ Concept Web — How 24 HR oxybutynin chloride 5 MG Extended Release... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR oxybutynin chloride 5 MG Extended Release Oral Tablet RxCUI 863636

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Oxybutynin 32675
    • Oxybutynin chloride 54251
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ditropan 151651
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Oxybutynin Extended Release Oral Tablet 373194
    • Oxybutynin chloride Extended Release Oral Tablet 2648583
    • Oxybutynin Oral Product 1160155
    • Oxybutynin Pill 1160156
    • Oxybutynin chloride Oral Product 2659390
    • Oxybutynin chloride Pill 2662465
    • Oxybutynin Extended Release Oral Tablet [Ditropan] 863621
    • Oxybutynin chloride Extended Release Oral Tablet [Ditropan] 2657996
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Oxybutynin chloride 5 MG 863635
    • 24 HR oxybutynin chloride 5 MG Extended Release Oral Tablet [Ditropan] 863638
    • Oxybutynin chloride 5 MG [Ditropan] 863637

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Oxybutynin chloride 5 MG SCDC · 863635
  • Oxybutynin Extended Release Oral Tablet SCDF · 373194
  • Oxybutynin chloride Extended Release Oral Tablet SCDFP · 2648583
  • Oxybutynin Oral Product SCDG · 1160155
  • Oxybutynin Pill SCDG · 1160156
  • Oxybutynin chloride Oral Product SCDGP · 2659390
  • Oxybutynin chloride Pill SCDGP · 2662465

Brand-Name Concepts

  • 24 HR oxybutynin chloride 5 MG Extended Release Oral Tablet [Ditropan] SBD · 863638
  • Oxybutynin chloride 5 MG [Ditropan] SBDC · 863637
  • Oxybutynin Extended Release Oral Tablet [Ditropan] SBDF · 863621
  • Oxybutynin chloride Extended Release Oral Tablet [Ditropan] SBDFP · 2657996
  • Ditropan Oral Product SBDG · 1172508
  • Ditropan Pill SBDG · 1172509
  • Ditropan BN · 151651

📦 FDA Products & Package NDCs

48 products · 118 package NDCs
118 package NDCs map to RxCUI 863636 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70771-1087-06 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-... oxybutynin Zydus Lifesciences Limited 2017-08-10
70771-1087-09 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-... oxybutynin Zydus Lifesciences Limited 2017-08-10
70771-1088-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771... oxybutynin Zydus Lifesciences Limited 2017-08-10
70771-1088-03 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-... oxybutynin Zydus Lifesciences Limited 2017-08-10
70771-1088-04 10 BLISTER PACK in 1 CARTON (70771-1088-4) / 10 TABLET, FIL... oxybutynin Zydus Lifesciences Limited 2017-08-10
70771-1088-05 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771... oxybutynin Zydus Lifesciences Limited 2017-08-10
70771-1088-06 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-... oxybutynin Zydus Lifesciences Limited 2017-08-10
70771-1088-09 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-... oxybutynin Zydus Lifesciences Limited 2017-08-10
71335-2330-01 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2330-1) Oxybutynin Chloride Extended Release Bryant Ranch Prepack 2024-01-18
71335-2330-02 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2330-2) Oxybutynin Chloride Extended Release Bryant Ranch Prepack 2024-01-18
72189-0130-30 30 TABLET in 1 BOTTLE (72189-130-30) OXYBUTYNIN CHLORIDE direct rx 2020-11-11
72189-0131-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-131-30) OXYBUTYNIN CHLORIDE direct rx 2020-11-11
72888-0030-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-030-01) Oxybutynin Chloride Advagen Pharma Limited 2020-10-27
72888-0030-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-030-05) Oxybutynin Chloride Advagen Pharma Limited 2024-07-10
72888-0031-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-031-01) Oxybutynin Chloride Advagen Pharma Limited 2020-10-27
72888-0031-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-031-05) Oxybutynin Chloride Advagen Pharma Limited 2024-07-10
72888-0032-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-032-01) Oxybutynin Chloride Advagen Pharma Limited 2020-10-27
72888-0032-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-032-05) Oxybutynin Chloride Advagen Pharma Limited 2024-07-10
Observed labelers: Zydus Lifesciences Limited (18) · Zydus Pharmaceuticals USA Inc. (18) · Amneal Pharmaceuticals LLC (13) · Aphena Pharma Solutions - Tennessee, LLC (10) · Rising Pharma Holdings, Inc. (7) · Advagen Pharma Limited (6) · +13 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.